[Congenital myasthenic syndrome (CMS) caused by postsynaptic defects].
Sonoda
Y
Y
Department of Neurology, Minamikyushu National Hospital.
Fukunaga
H
H
D000109:Acetylcholine / Q000378:metabolism; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D003937:Diagnosis, Differential; D006801:Humans; D009154:Mutation; D020294:Myasthenic Syndromes, Congenital / Q000145:classification / Q000209:etiology; D011802:Quinidine / Q000627:therapeutic use; D011950:Receptors, Cholinergic / Q000235:genetics / Q000378:metabolism
D000889:Anti-Arrhythmia Agents; D011950:Receptors, Cholinergic; D011802:Quinidine; D000109:Acetylcholine